Artificial intelligence
Submitted by Anonymous (not verified) on 3 March 2026 - 10:54
Artificial intelligence
Veterinary pre-submission meeting request form - in accordance with Regulation (EU) No 2019/6
Submitted by Anonymous (not verified) on 3 March 2026 - 9:00
Veterinary pre-submission meeting request form - in accordance with Regulation (EU) No 2019/6
Fees for veterinary medicines
Submitted by Anonymous (not verified) on 2 March 2026 - 16:47
Fees for veterinary medicines
Herbal medicinal product: Hyperici herba, Hypericum perforatum L.,Cimicifuga racemosa (L.) Nutt., F: Assessment finalised
Submitted by Anonymous (not verified) on 2 March 2026 - 16:32
Herbal medicinal product: Hyperici herba, Hypericum perforatum L.,Cimicifuga racemosa (L.) Nutt., F: Assessment finalised
Veterinary medicines European public assessment report (EPAR): Lotilaner / Milbemycin Elanco, lotilaner,milbemycin oxime, Status: Authorised
Submitted by Anonymous (not verified) on 2 March 2026 - 16:22
Veterinary medicines European public assessment report (EPAR): Lotilaner / Milbemycin Elanco, lotilaner,milbemycin oxime, Status: Authorised
Human medicines European public assessment report (EPAR): Nivestim, filgrastim, Date of authorisation: 07/06/2010, Revision: 32, Status: Authorised
Submitted by Anonymous (not verified) on 2 March 2026 - 16:15
Human medicines European public assessment report (EPAR): Nivestim, filgrastim, Date of authorisation: 07/06/2010, Revision: 32, Status: Authorised
Human medicines European public assessment report (EPAR): Retacrit, epoetin zeta, Date of authorisation: 18/12/2007, Revision: 34, Status: Authorised
Submitted by Anonymous (not verified) on 2 March 2026 - 16:08
Human medicines European public assessment report (EPAR): Retacrit, epoetin zeta, Date of authorisation: 18/12/2007, Revision: 34, Status: Authorised
Human medicines European public assessment report (EPAR): Lamzede, velmanase alfa, Date of authorisation: 23/03/2018, Revision: 7, Status: Authorised
Submitted by Anonymous (not verified) on 2 March 2026 - 16:02
Human medicines European public assessment report (EPAR): Lamzede, velmanase alfa, Date of authorisation: 23/03/2018, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Fingolimod Accord, fingolimod, Date of authorisation: 25/06/2020, Revision: 11, Status: Authorised
Submitted by Anonymous (not verified) on 2 March 2026 - 15:58
Human medicines European public assessment report (EPAR): Fingolimod Accord, fingolimod, Date of authorisation: 25/06/2020, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Rasilez, aliskiren, Date of authorisation: 22/08/2007, Revision: 28, Status: Authorised
Submitted by Anonymous (not verified) on 2 March 2026 - 15:55
Human medicines European public assessment report (EPAR): Rasilez, aliskiren, Date of authorisation: 22/08/2007, Revision: 28, Status: Authorised